Quoin Pharmaceuticals annual return on equity
2022
2023
2024
2025
Quoin Pharmaceuticals Return on Equity (ROE) Growth & History (QNRX)
Quoin Pharmaceuticals's return on equity was −141.59% for fiscal 2025.
View full Quoin Pharmaceuticals company overviewQuoin Pharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −141.59% | −21.03 pp |
| 2024 | 2024-12-31 | −120.55% | +12.36 pp |
| 2023 | 2023-12-31 | −132.92% | +99.77 pp |
| 2022 | 2022-12-31 | −232.68% | — |
Quoin Pharmaceuticals quarterly return on equity
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −84.54% | +2.65 pp |
| Q1 2026 | 2026-03-31 | −45.66% | +4.73 pp |
| Q4 2025 | 2025-12-31 | −73.05% | −41.49 pp |
| Q3 2025 | 2025-09-30 | −590.72% | −554.34 pp |
| Q2 2025 | 2025-06-30 | −87.20% | −63.42 pp |
| Q1 2025 | 2025-03-31 | −50.39% | −18.92 pp |
| Q4 2024 | 2024-12-31 | −31.56% | −0.21 pp |
| Q3 2024 | 2024-09-30 | −36.38% | −13.00 pp |
| Q2 2024 | 2024-06-30 | −23.78% | −2.69 pp |
| Q1 2024 | 2024-03-31 | −31.47% | −3.06 pp |
| Q4 2023 | 2023-12-31 | −31.35% | −7.20 pp |
| Q3 2023 | 2023-09-30 | −23.37% | +77.62 pp |
| Q2 2023 | 2023-06-30 | −21.08% | — |
| Q1 2023 | 2023-03-31 | −28.42% | — |
| Q4 2022 | 2022-12-31 | −24.15% | — |
| Q3 2022 | 2022-09-30 | −100.99% | — |
Quoin Pharmaceuticals return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Quoin Pharmaceuticals's return on equity increased from −232.68% to −141.59%, a change of +91.09 percentage points. The latest reported quarter, Q2 2026, shows −84.54%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quoin Pharmaceuticals source filings ↗